1. Home
  2. DERM vs FGBI Comparison

DERM vs FGBI Comparison

Compare DERM & FGBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DERM
  • FGBI
  • Stock Information
  • Founded
  • DERM 2014
  • FGBI 1934
  • Country
  • DERM United States
  • FGBI United States
  • Employees
  • DERM N/A
  • FGBI N/A
  • Industry
  • DERM Biotechnology: Pharmaceutical Preparations
  • FGBI Savings Institutions
  • Sector
  • DERM Health Care
  • FGBI Finance
  • Exchange
  • DERM Nasdaq
  • FGBI Nasdaq
  • Market Cap
  • DERM 124.4M
  • FGBI 136.1M
  • IPO Year
  • DERM 2021
  • FGBI N/A
  • Fundamental
  • Price
  • DERM $5.12
  • FGBI $11.41
  • Analyst Decision
  • DERM Strong Buy
  • FGBI
  • Analyst Count
  • DERM 3
  • FGBI 0
  • Target Price
  • DERM $9.50
  • FGBI N/A
  • AVG Volume (30 Days)
  • DERM 159.2K
  • FGBI 12.1K
  • Earning Date
  • DERM 11-12-2024
  • FGBI 10-31-2024
  • Dividend Yield
  • DERM N/A
  • FGBI 4.93%
  • EPS Growth
  • DERM N/A
  • FGBI N/A
  • EPS
  • DERM 0.04
  • FGBI 0.85
  • Revenue
  • DERM $77,681,000.00
  • FGBI $95,480,000.00
  • Revenue This Year
  • DERM N/A
  • FGBI N/A
  • Revenue Next Year
  • DERM $37.38
  • FGBI N/A
  • P/E Ratio
  • DERM N/A
  • FGBI $13.39
  • Revenue Growth
  • DERM 26.38
  • FGBI 0.27
  • 52 Week Low
  • DERM $2.85
  • FGBI $8.39
  • 52 Week High
  • DERM $8.11
  • FGBI $13.32
  • Technical
  • Relative Strength Index (RSI)
  • DERM 40.57
  • FGBI 67.16
  • Support Level
  • DERM $5.00
  • FGBI $10.54
  • Resistance Level
  • DERM $5.82
  • FGBI $11.25
  • Average True Range (ATR)
  • DERM 0.45
  • FGBI 0.27
  • MACD
  • DERM -0.07
  • FGBI 0.10
  • Stochastic Oscillator
  • DERM 8.99
  • FGBI 100.00

About DERM Journey Medical Corporation

Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's portfolio includes eight branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the United States. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.

About FGBI First Guaranty Bancshares Inc.

First Guaranty Bancshares Inc provides personalized commercial banking services to its customers in Louisiana, through several banking facilities. The principal business activity of the company includes attracting deposits and investing it together with funds generated from operations and borrowings insecurities and in lending activities to serve the credit needs of its customer base. The company offers commercial real estate loans, commercial and industrial loans, construction and land development loans, agricultural and farmland loans, and to a lesser extent, consumer and multifamily loans.

Share on Social Networks: